Market Dynamics

The Future is Now – an interview with Ted Driscoll

By Claremont Creek Alerts / October 7, 2010 / 0 Comments

October 6, 2010  source: (registration required for site access) This interview with Ted Driscoll was originally published on the Private Equity Central website. The Future is Now Bionic limbs may sound like something out of the future, but it is not. It is here. Now. Claremont Creek Ventures, a firm with $310 million in […]

Read More

Early Stage Investing Is Alive and Well

By Randy Hawks / October 1, 2010 / 1 Comment

What a difference a year makes. In 2009, with the nation’s economic storm raging with gale-force winds, most venture capitalists pulled in their horns, trimmed the size of their startup portfolios and only rarely invested in new startups, whether they were promising or not. When they did invest, it was mostly in later-stage rounds. Some […]

Read More

Digging Deep into the Relationship of Research and Healthcare Investing

By Brad Webb / September 21, 2010 / 0 Comments

I enjoyed reading Regis Kelly’s insightful discussions about the state of academic research, and the September 14 blog post in Xconomy, The Social Contract of Science, was no exception. As the director of the California Institute for Quantitative Biosciences, the QB3 Institute, Regis enjoys a close and intimate perspective on academic research and its relation […]

Read More

Looking Ahead in Healthcare Investing: Focus on Tibion Bionic Technologies

By John Steuart / September 11, 2010 / 2 Comments

At the beginning of this year, I was cautiously optimistic that 2010 would be a better year than 2009 for investments in healthcare information technology. Now that we have made our way through two-thirds of 2010, I’m happy to see that things are going well despite the fact that the U.S economy is not cooperating […]

Read More

Will the Stem Cell Ruling Affect Venture Capital Investing?

By Brad Webb / September 1, 2010 / 0 Comments

September 1, 2010 source: xconomy Brad Webb, Venture Partner at Claremont Creek Ventures, was featured today on the xcononomy website discussing the implications for venture investment of the recent judicial ruling regarding federal funding for stem cell research. Last week’s federal district court ruling ordering an immediate halt in federal funding for stem cell research […]

Read More

Idea Flow

By Ted Driscoll / July 29, 2010 / 0 Comments

Recently, I’ve been hearing a lot about how the VC model is dead, and the venture capital industry is drying up. This is justified by the lack of conventional exits and liquidity events, meaning the venture capital funds can’t return cash to their investors. While we have clearly been going through a flat spot in […]

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat_Boldhaber7718 -1200px


Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

Brad_Webb8124 1200px crop


Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

Randy_Hawks7690 -1200px


Randy Hawks is a co-founder of Claremont Creek Ventures.

Post Categories